Showing results (11-20 of 9,102) with videos related to
Sort By:
Pageof 911
Inorganic Chemistry|July 22, 2020
Exploring Reactivity and Regioselectivity of Dimerization of Paramagnetic Endohedral MetallofullerenesLihong Wang, Yang WangInternational Journal of Environmental Research and Public Health|September 5, 2017
On Consistency Test Method of Expert Opinion in Ecological Security AssessmentZaiwu Gong, Lihong WangJournal of Environmental Sciences (China)|July 29, 2009
Effect of external and internal phosphate status on arsenic toxicity and accumulation in rice seedlingsLihong Wang, Guilan DuanCancer Biology & Therapy|September 26, 2022
Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progressionQingxia Fang, Jingyang Lin, Liang Gao, et al.Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|November 11, 2010
Effects of transfection of ICAP-1α and its mutants on adhesion and migration of 2H-11 cellsJie Zhang, Wangcui Luo, Zhengxiang Liu, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 3, 2021
Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancerXiaochun Zheng, Xiuli Yang, Jingyang Lin, et al.Biomacromolecules|December 1, 2025
Synthesis and Characterization of Biomimetic Thermoplastic Polyurethanes and Nanocomposites with l-Lysine DiisocyanateCharlie Bateman, Chenghao Yao, Jingyang Lin, et al.Circulation|November 30, 2005
TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in miceLihong Wang, Donna H WangPlos One|June 22, 2026
Economic evaluation of the second-line regimen of liposome irinotecan (II) combined with 5-FU/LV versus placebo combined with 5-FU/LV for locally advanced or metastatic pancreatic ductal adenocarcinoma in ChinaJinlong Huang, Hanyun Ye, Jingyang Lin, et al.Clinical Epidemiology|September 22, 2025
Post-Marketing Safety Concerns with Efgartigimod alfa: A Pharmacovigilance Analysis Based on the Food and Drug Administration Adverse Event Reporting System DatabaseJinlong Huang, Hanyun Ye, Jingyang Lin, et al.Pageof 911